Adenomyomatosis of the gallbladder (AG) is a condition in which the inner wall of the gallbladder becomes thickened and nodular. It is a very common condition, affecting up to 10% of people in some populations. AG is often asymptomatic and is usually discovered incidentally during imaging for other issues. However, it can cause symptoms such as abdominal pain, nausea, and vomiting. In some cases, AG can lead to complications such as gallbladder cancer and cholecystitis. As such, it is important for doctors to be aware of the condition and to understand how it can be diagnosed and managed. This article will provide an overview of AG, including its causes, diagnosis, and treatment.
Adenomyomatosis of the gallbladder is a condition in which the inner wall of the gallbladder becomes thickened and nodular. It is caused by a buildup of mucus, bile, and other substances in the gallbladder. This buildup leads to the formation of small nodules, which can range in size from a few millimeters to several centimeters. AG can affect one or both sides of the gallbladder, and it can also affect different parts of the organ.
The exact cause of AG is not known. However, there are several risk factors that can increase a person’s likelihood of developing the condition. These risk factors include obesity, diabetes, and a high-fat diet. In addition, certain medications, such as steroids, can also increase the risk of developing AG.
AG is usually diagnosed during imaging tests, such as an ultrasound or CT scan. During these tests, the doctor will be able to see the thickened and nodular walls of the gallbladder. In some cases, a biopsy may also be performed to confirm the diagnosis.
In most cases, AG does not require treatment. However, if the condition is causing symptoms, it may be necessary to treat the underlying cause. For example, if the patient is overweight, they may be advised to lose weight. If the patient is taking steroids, they may be advised to stop taking them. In some cases, surgery may be necessary. This is usually only recommended if the patient is experiencing severe symptoms or if there is a risk of complications. Surgery may involve removing the gallbladder, or it may involve removing the nodules.
Adenomyomatosis of the gallbladder is a common condition that can cause symptoms such as abdominal pain, nausea, and vomiting. It is usually asymptomatic and is usually discovered incidentally during imaging tests. In most cases, AG does not require treatment, but if the patient is experiencing severe symptoms or if there is a risk of complications, surgery may be necessary. It is important for doctors to be aware of the condition and to understand how it can be diagnosed and managed.
1.
Getting Lung Cancer Screening Staff Involved Improved Tobacco Cessation
2.
Formaldehyde releasers found in common personal care products used especially by Black and Latina women
3.
Personalized Breast Cancer Treatment; Insights Into HPV in Men; Exercise and Cancer
4.
'Ticking Time Bomb'; Jimmy Carter's Lasting Impact on Cancer; Breast Cancer-CVD Link
5.
GLP-1 Receptor antagonists used in a study allay fears about thyroid cancer.
1.
Biomimetic Nanovesicles Target Senescent-Escape Cancer Stem Cells in Breast Cancer
2.
Exploring the Mysteries of Myxoma: A New Frontier in Medical Research
3.
Direct Oral Anticoagulants (DOACs) in Atrial Fibrillation: A Comprehensive Review
4.
Unraveling the Mystery of Non-Caseating Granulomas: A Comprehensive Guide
5.
Chemotherapy Advances: Albumin I.V., Trastuzumab, Liposomal Doxorubicin & More
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.
2.
Navigating the Complexities of Ph Negative ALL - Part X
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
4.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation